Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial

Trials
Leopoldo J CabassaLawrence A Palinkas

Abstract

The risk for obesity is twice as high in people with serious mental illness (SMI) compared to the general population. Racial and ethnic minority status contribute additional health risks. The aim of this study is to describe the protocol of a Hybrid Trial Type 1 design that will test the effectiveness and examine the implementation of a peer-led healthy lifestyle intervention in supportive housing agencies serving diverse clients with serious mental illness who are overweight or obese. The Hybrid Trial Type 1 design will combine a randomized effectiveness trial with a mixed-methods implementation study. The effectiveness trial will test the health impacts of a peer-led healthy lifestyle intervention versus usual care in supportive housing agencies. The healthy lifestyle intervention is derived from the Group Lifestyle Balanced Program, lasts 12 months, and will be delivered by trained peer specialists. Repeated assessments will be conducted at baseline and at 6, 12, and 18 months post randomization. A mixed-methods (e.g., structured interviews, focus groups, surveys) implementation study will be conducted to examine multi-level implementation factors and processes that can inform the use of the healthy lifestyle intervention in...Continue Reading

Associated Clinical Trials

References

Jul 15, 1999·Psychological Medicine·S BrownC Thompson
Nov 22, 2000·Schizophrenia Bulletin·L DixonA Lehman
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Nov 28, 2002·Diabetes Care·UNKNOWN Diabetes Prevention Program (DPP) Research Group
Aug 6, 2003·Medicine and Science in Sports and Exercise·Cora L CraigPekka Oja
Mar 9, 2004·The Journal of Clinical Psychiatry·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Apr 1, 2004·American Journal of Public Health·Sam TsemberisMaria Nakae
Jul 16, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Martha M. KatoMercedes Gonzalez-Blanco
Jun 16, 2005·Schizophrenia Bulletin·Patrick W CorriganLorraine Keck
Jul 22, 2005·Journal of Health Psychology·Kenneth A Wallston
Oct 7, 2005·The Journal of Nervous and Mental Disease·Gail L DaumitLisa B Dixon
Dec 20, 2005·Schizophrenia Research·Guy FaulknerGary Remington
Apr 21, 2006·The New England Journal of Medicine·Stephen W Lagakos
Apr 29, 2006·The Journal of Behavioral Health Services & Research·Matthew ChinmanLarry Davidson
Oct 19, 2006·Drug and Alcohol Dependence·John S CacciolaKevin G Lynch
Nov 23, 2006·Psychosomatics·Tracy SteckerSarita Prajapati
Mar 7, 2007·Administration and Policy in Mental Health·Lauren B Gates, Sheila H Akabas
May 31, 2007·The American Journal of Orthopsychiatry·Leopoldo J Cabassa, Luis H Zayas
Aug 1, 2007·AIDS Patient Care and STDs·Judith B BradfordWilliam Cunningham
Jul 10, 2007·Administration and Policy in Mental Health·Gregory A AaronsChristine M Walrath-Greene
Oct 18, 2007·JAMA : the Journal of the American Medical Association·John W Newcomer, Charles H Hennekens
Dec 19, 2007·Administration and Policy in Mental Health·Charles GlissonUNKNOWN Research Network on Youth Mental Health
Aug 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Mario Alvarez-JiménezPatrick D McGorry
Sep 10, 2008·American Journal of Preventive Medicine·Ronald T AckermannDavid G Marrero
Oct 31, 2008·The Canadian Journal of Cardiology·Robert Ross, Peter M Janiszewski
Mar 7, 2009·Journal of the American Board of Family Medicine : JABFM·Nancy E MordenStephen J Bartels
Mar 17, 2009·American Journal of Preventive Medicine·David B AllisonJonathan E Alpert
May 2, 2009·The Diabetes Educator·Kate LorigJean Armas
May 23, 2009·Journal of the American College of Cardiology·Carl J LavieHector O Ventura
Sep 18, 2009·Contemporary Clinical Trials·Jeffrey A KatulaDavid C Goff
Dec 1, 2009·American Journal of Preventive Medicine·M Kaye KramerTrevor J Orchard

❮ Previous
Next ❯

Citations

Oct 5, 2016·Journal of Psychiatric Research·Leopoldo J CabassaAna Stefancic
Dec 19, 2018·Health & Social Work·Carolina Vélez-GrauLeopoldo J Cabassa
Aug 9, 2019·Journal of Developmental and Behavioral Pediatrics : JDBP·Kimberly S HsiungDavid J Kolko
Dec 15, 2015·CA: a Cancer Journal for Clinicians·Lara C WeinsteinRichard C Wender
Dec 20, 2018·Administration and Policy in Mental Health·Lauren BochicchioLeopoldo J Cabassa
Jul 17, 2020·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Lara Carson WeinsteinLeopoldo J Cabassa
Feb 6, 2017·Translational Behavioral Medicine·Kathleen O'HaraLeopoldo J Cabassa
May 2, 2020·JMIR Mental Health·Reham AHameed Shalaby, Vincent Io Agyapong
Dec 19, 2020·Psychiatric Services : a Journal of the American Psychiatric Association·Leopoldo J CabassaMonica Medina McCurdy
Dec 10, 2020·Pilot and Feasibility Studies·Nicole PearsonLuke Wolfenden
Mar 5, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·Ana StefancicLeopoldo J Cabassa
Mar 5, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·Ana StefancicLeopoldo J Cabassa

❮ Previous
Next ❯

Software Mentioned

Peer GLB
Atlas
SAS
GLB
RMASS
ti

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.